文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

磁共振-only前列腺放疗中金标手动定位的评估

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
PubMed 文献 · Radiat Oncol · 2018-06-05

本研究在临床环境中由5名放疗技师对16例前列腺癌患者的金标分别采用单序列与多序列磁共振进行手动定位。多序列定位精确标记数由38/48增至45/48,手动磁共振与CT定位的标记间距差异平均为0.6±0.6毫米。作者认为钙化与运动导致错误定位风险仍过高,尚不能仅用人工磁共振金标定位。

要点

  • 多序列磁共振手动定位的精确金标数由单序列的38/48增至45/48。
  • 精确金标在三个方向上质心95%一致性界限均在0.25毫米以内。
  • 手动磁共振与CT定位的标记间距差异平均为0.6±0.6毫米。

核心结论

  • 两种场景下金标分类正确时,手动磁共振定位的精密度与准确度均较高,与CT金标定位相当。
  • 多序列定位表现优于单序列定位,但钙化与运动导致错误患者定位风险仍过高,尚不能仅用人工磁共振金标定位。
  • 作者提出了可能克服当前挑战的策略。

研究设计与样本

  • 研究由5名临床放疗技师独立对16例前列腺癌患者植入的金标进行定位。
  • 两种场景分别为采用单一磁共振序列和采用多序列组合进行定位。
  • 以单金标95%一致性界限、质心95%一致性界限和标记间距分别评估观察者间精密度与准确度。

主要发现

  • 精确定位(一致性界限<2毫米)的金标数由单序列的38/48增至多序列的45/48。
  • 多序列定位时,3例患者中各有1/3植入金标出现不精确定位,共3/48枚金标。
  • 精确定位的金标在各方向上质心95%一致性界限均在0.25毫米以内。
  • 手动磁共振定位与CT定位的标记间距差异平均(±1标准差)为0.6±0.6毫米。

局限性

  • 钙化和运动的存在使错误患者定位的风险仍然过高,尚不能仅使用手动金标定位。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of intraprostatic gold fiducial markers (FMs) ensures highly accurate and precise image-guided radiation therapy for patients diagnosed with prostate cancer thanks to the ease of localising FMs on photon-based imaging, like Computed Tomography (CT) images. Recently, Magnetic Resonance (MR)-only radiotherapy has been proposed to simplify the workflow and reduce possible systematic uncertainties. A critical, determining factor in the accuracy of such an MR-only simulation will be accurate FM localisation using solely MR images. PURPOSE: The aim of this study is to evaluate the performances of manual MR-based FM localisation within a clinical environment. METHODS: We designed a study in which 5 clinically involved radiation therapy technicians (RTTs) independently localised the gold FMs implanted in 16 prostate cancer patients in two scenarios: employing a single MR sequence or a combination of sequences. Inter-observer precision and accuracy were assessed for the two scenarios for localisation in terms of 95% limit of agreement on single FMs (LoA)/ centre of mass (LoA CM) and inter-marker distances (IDs), respectively. RESULTS: The number of precisely located FMs (LoA <2 mm) increased from 38/48 to 45/48 FMs when localisation was performed using multiple sequences instead of single one. When performing localisation on multiple sequences, imprecise localisation of the FMs (3/48 FMs) occurred for 1/3 implanted FMs in three different patients. In terms of precision, we obtained LoA CM within 0.25 mm in all directions over the precisely located FMs. In terms of accuracy, IDs difference of manual MR-based localisation versus CT-based localisation was on average (±1 STD) 0.6 ±0.6 mm. CONCLUSIONS: For both the investigated scenarios, the results indicate that when FM classification was correct, the precision and accuracy are high and comparable to CT-based FM localisation. We found that use of multiple sequences led to better localisation performances compared with the use of single sequence. However, we observed that, due to the presence of calcification and motion, the risk of mislocated patient positioning is still too high to allow the sole use of manual FM localisation. Finally, strategies to possibly overcome the current challenges were proposed.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Maspero M, Seevinck PR, Willems NJW, et al. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy. Radiat Oncol. 2018. PMID: 29871656. doi:10.1186/s13014-018-1029-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。